GSK PLC Replacement - Total Voting Rights

RNS Number : 3614J

GSK PLC

04 April 2024

 

The following amendment has been made to the 'Total Voting Rights and Capital' announcement released on 2 April 2024 at 15:00 under RNS No 9551I.

 

A typographical correction to the total number of voting rights in the Company.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

GSK plc

 

Correction - Total Voting Rights and Capital

 

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 31 March 2024 consisted of 4,314,051,101 shares of 31 ¼ pence each ('Ordinary Shares'), of which 169,171,155 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,144,879,946.  This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Notifications may be sent to [e-mail].

 

 

V A Whyte

Company Secretary

 

4 April 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

TVRIIMBTMTMMBJI